# EMRESERVA to Enhance Cognitive Reserve in Multiple Sclerosis

> **NCT05546424** · — · COMPLETED · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 58 (actual)

## Conditions studied

- Cognitive Change

## Interventions

- **BEHAVIORAL:** EMRESERVA

## Key facts

- **NCT ID:** NCT05546424
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-19
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05546424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05546424, "EMRESERVA to Enhance Cognitive Reserve in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05546424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*